Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine adductor canal block for analgesia after total knee arthroplasty
ChiCTR2300074254Phase 4Completed
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Jul 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Postoperative static pain score, Postoperative dynamic pain score and 1 more. Started Jul 2023; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300074254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074254.